Maksim Labkouski
Amedisys (NASDAQ:AMED) has received a request from the US Department of Justice for more information regarding its planned merger with UnitedHealth Group (NYSE:UNH), a development that could significantly extend the timetable for the $3.29B deal.
The healthcare services provider said in a filing made Thursday that it had received a “second request” from the DOJ on Aug. 4.
In May, Amedisys announced it had agreed to be acquired by Option Health Care (OPHC) through an all-stock deal that valued Amedisys at $97.38 per share. Amedisys pulled out of the deal in July, opting instead to be acquired by United Health’s Optum division for $101 per share in cash, or around $3.29B.
The second request comes amid reports that the DOJ has launched an antitrust probe into the managed care sector.
More on Amedisys:
Amedisys Non-GAAP EPS of $1.37 beats by $0.28, revenue of $552.97M misses by $15.23M
Amedisys cut to hold at Jefferies as rival bids to UNH unlikely
UnitedHealth – Amedisys to combine in $101 per share all-cash deal
Amedisys-UnitedHealth And 16 Other Opportunities In The Merger Arbitrage Space
#DOJ #requests #info #Amedisys #UnitedHealth #merger #NASDAQAMED
